Location History:
- Newfield, ME (US) (1998 - 2000)
- Falmouth, ME (US) (2004)
- Portland, ME (US) (2018)
Company Filing History:
Years Active: 1998-2018
Title: Joseph H. Crabb: Innovator in Pharmaceutical Grade Lantibiotics
Introduction
Joseph H. Crabb is a notable inventor based in Newfield, ME (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the production and purification of lantibiotics. With a total of 5 patents to his name, Crabb's work has the potential to impact the pharmaceutical industry positively.
Latest Patents
Crabb's latest patents include innovative methods and systems for producing pharmaceutical grade lantibiotics. These methods are designed for efficient and cost-effective production, ensuring that the lantibiotics produced have high purity suitable for pharmaceutical use. One of his key patents discloses a method for purifying lantibiotics from crude or partially purified solutions. This method is particularly effective for nisin, a well-known lantibiotic, and involves forming an incubation mixture with a proteolytic enzyme to optimize selective proteolytic activity.
Career Highlights
Joseph H. Crabb is associated with Immucell Corporation, where he applies his expertise in pharmaceutical development. His work focuses on enhancing the production processes of vital pharmaceutical compounds, contributing to advancements in medical treatments.
Collaborations
Crabb has collaborated with notable colleagues, including Nathan B. Turner and Michael S. Luck. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.
Conclusion
Joseph H. Crabb's contributions to the field of pharmaceutical grade lantibiotics exemplify the importance of innovation in medicine. His patents and collaborative efforts continue to pave the way for advancements in pharmaceutical production and purification methods.